Influenza vaccination among healthy employees: A cost-benefit analysis

被引:46
作者
Kumpulainen, V
Makela, M
机构
[1] NATL RES & DEV CTR WELF & HLTH,STAKES SERV & QUAL,FIN-00531 HELSINKI,FINLAND
[2] HELSINKI CITY HLTH CTR,OCCUPAT HLTH UNIT,HELSINKI,FINLAND
关键词
D O I
10.3109/00365549709035881
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The cost of influenza vaccination and influenza infections was evaluated in a controlled study among healthy municipal homemakers. Acute respiratory infections sere followed clinically and with laboratory samples for 8 months. Full follow-up was achieved in 351 persons in the intervention group, of whom 47% obtained vaccination, and 492 controls. Influenza infection was confirmed in 10 employees (8 of these in the control group) and other viral infections in 6 employees (5 of them controls). All infections occurred in non-vaccinated persons. The relative risk of infection in the control group was 2.9 (95% CI 0.6-13.4) for influenza and 3.1 (0.9-10.8) for all respiratory infections. The mean sick leave for influenza was 4.9 days. The cost per immunization was FIM 141, and the average cost per influenza infection FIM 1183. The cost per infection averted was FIM 6270, and the equivalent cost for immunization FIM 26.52. Influenza vaccination had a slight protective effect against both influenza and other respiratory infections. The cost of vaccination programmes exceeded the benefit from averted infections. Optimal vaccination strategies for healthy adults need to be planned individually with minimal loss of working time.
引用
收藏
页码:181 / 185
页数:5
相关论文
共 21 条
  • [1] [Anonymous], 1996, IMMUNISATION INFECT
  • [2] *DIR GEN PUBL HLTH, 1995, INFL 1995
  • [3] *EPI NYT, 1995, 39 STAT SER
  • [4] THE EFFICACY OF INFLUENZA VACCINATION IN ELDERLY INDIVIDUALS - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    GOVAERT, TME
    THIJS, CTMCN
    MASUREL, N
    SPRENGER, MJW
    DINANT, GJ
    KNOTTNERUS, JA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (21): : 1661 - 1665
  • [5] HELLIWELL BE, 1988, CAN J PUBLIC HEALTH, V79, P175
  • [6] HOVI T, 1996, SUOM LAAKARIL, V51, P2101
  • [7] KEKKI P, 1985, U HELSINKI DEPT PRIM, V2
  • [8] LEVY E, 1992, REV EPIDEMIOL SANTE, V40, P285
  • [9] MACNAIR A, 1991, CASE COMPREHENSIVE I, P25
  • [10] THE IMPACT AND COST OF INFLUENZA IN THE ELDERLY
    MCBEAN, AM
    BABISH, JD
    WARREN, JL
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (18) : 2105 - 2111